PARNAXLAB (PARNAXLAB) Fair Value & Analysis

IN · Market cap ₹1.7B

P PARNAXLAB PARNAXLAB · BSE

Price₹146.35

Fair Value₹205.07

Upside+40.1%

Quality53/100

Watch PARNAXLAB for free — get notified when fair value or trend changes. Watch for free

Evidence: Medium Range ₹153.80 – ₹256.34

Fair value as of: Jul 5, 2026

From 14 valuation models · updated today

Share price +16.2% over the past month.

Price vs Fair Value (12 months)

12‑month range ₹101.05 – ₹165.00 · fair‑value band ₹153.80 – ₹256.34 · the ₹146.35 price screens below the ₹205.07 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

PARNAXLAB (PARNAXLAB) currently trades at ₹146.35, while our model-based Fair Value estimate is ₹205.07 — implying the stock looks roughly 40.1% undervalued today. We read business quality at 53/100 (solid quality). Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

Over the trailing twelve months, PARNAXLAB generated revenue of ₹2.5B at a net margin of 4.7%. Revenue grew 41.9% year over year. It earns a return on equity of 13.2%. Net debt stands at ₹742M. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹153.80 (bear case) to ₹256.34 (bull case); at ₹146.35, the current price sits below that range. The share trades about 20% below its 52-week high and 52% above its 52-week low, currently above its 200-day average.

Key figures & financial health

Revenue (TTM) ₹2.5B

Revenue growth (YoY) +41.9%

Net margin 4.7%

Return on equity 13.2%

Free cash flow −₹93.1M FY2026

P/E ratio 14.3

More key figures

Operating margin 4.1%

EPS (TTM) ₹10.27

EPS growth (YoY) -25.5%

Net debt ₹742M FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

PARNAXLAB reported revenue of ₹2.5B in FY2026 versus ₹1.6B in FY2022, a compound +11.1%/yr. Reported net income was ₹118M in FY2026, compounding +9.3%/yr from FY2022.

Revenue +11.1%/yr

FY22 ₹1.6B

FY23 ₹1.7B

FY24 ₹1.9B

FY25 ₹1.9B

FY26 ₹2.5B

Net income +9.3%/yr

FY22 ₹82.4M

FY23 ₹86.2M

FY24 ₹96.1M

FY25 ₹115M

FY26 ₹118M

Is PARNAXLAB fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators

DCF Calculator Graham Number Peter Lynch Formula DDM Calculator Fama-French Model Intrinsic Value

📤 Share or link this analysis

𝕏 Post WhatsApp LinkedIn Reddit

🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

PARNAXLAB · Fair Value
₹205.07 +40%Fair Value
Calculator →

<a href="https://www.fairvalue-calculator.com/stock/PARNAXLAB" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:12px;box-sizing:border-box;font-family:system-ui,-apple-system,Segoe UI,Roboto,sans-serif;text-decoration:none;background:#0f1814;color:#eaf2ed;border:1px solid #2a3a30;border-radius:12px;padding:12px 16px;max-width:360px"><span style="line-height:1.35"><span style="font-size:12px;color:#9fb0a8">PARNAXLAB · Fair Value</span><br><b style="font-size:20px">₹205.07</b> <span style="color:#7BB290;font-weight:700;font-size:14px">+40%</span></span><span style="font-size:11px;color:#7BB290;font-weight:700;margin-left:auto;text-align:right;line-height:1.3">Fair&nbsp;Value<br>Calculator&nbsp;→</span></a>

Cite: Fair Value Calculator (2026). "PARNAXLAB Fair Value". https://www.fairvalue-calculator.com/stock/PARNAXLAB

Explore undervalued stocks

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is PARNAXLAB (PARNAXLAB) undervalued?

As of Jul 5, 2026, our model estimates a fair value of ₹205.07 versus a price of ₹146.35 — about +40% (undervalued). Model-based estimate, not financial advice.

What is the fair value of PARNAXLAB?

Our model-based fair value for PARNAXLAB is ₹205.07 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹146.35.

What is the quality score of PARNAXLAB?

PARNAXLAB has a Quality Score of 53/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of PARNAXLAB (PARNAXLAB)?

PARNAXLAB reported trailing-twelve-month revenue of about ₹2.5B (latest available figure, as of Jul 5, 2026).

What is the net profit margin of PARNAXLAB?

The net profit margin of PARNAXLAB is about 4.7%, meaning it keeps roughly 4.7% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.